Chimerix Inc (CMRX)

NASDAQ
2.440
+0.080(+3.39%)
समय के बाद
2.360
-0.080(-3.279%)
- रियल टाइम डेटा
  • वॉल्यूम:
    6,794,969
  • दिन की रेंज:
    2.280 - 2.540
  • 52 सप्ताह रेंज:
    1.270 - 7.420

CMRX समीक्षा

पिछला बंद
2.36
दिन की रेंज
2.28-2.54
आय
608K
खुला
2.33
52 सप्ताह रेंज
1.27-7.42
ईपीएस
-1.22
वॉल्यूम
6,794,969
मार्केट कैप
213.8M
लाभांश (यील्ड)
N/A
(N/A)
औसत वॉल्यूम (3एम)
6,291,735
पी/ई अनुपात
-1.93
बीटा
1.17
1- वर्ष बदलाव
-62.63%
बकाया शेयर
87,622,853
अगली कमाई तिथि
09 नव॰ 2022
Chimerix पर आपकी भावना क्या है?
या
अभी बाज़ार बंद हैं। वोटिंग बाजार का समय के दौरान खुली है।

Chimerix Inc कंपनी प्रोफाइल

Chimerix Inc कंपनी प्रोफाइल

Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company’s approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs include ONC201 a program for treating tumors which harbor the H3 K27M mutation in recurrent diffuse midline glioma patients; ONC206, an imipridone, Dopamine Receptor D2 (DRD2) antagonist, and caseinolytic protease P (ClpP) agonist that demonstrated enhanced non-competitive DRD2 antagonism relative to ONC201, which is in Phase I clinical trials to treat solid tumors; ONC212, an imipridone agonist of the orphan G protein-coupled receptors (GPCR) tumor suppressor GPR132, as well as ClpP for solid tumors and hematological malignancies, including pancreatic cancer and leukemias; and dociparstat sodium (DSTAT), which inhibits the activities of key proteins implicated in the resistance of acute myeloid leukemia blasts and leukemic stem cells to chemotherapy. The company has license agreements with Biomedical Advanced Research and Development Authority for the development of brincidofovir for use in the treatment of smallpox; Cantex Pharmaceuticals, Inc. to develop and commercialize a glycosaminoglycan compound; and SymBio Pharmaceuticals to develop, manufacture, and commercialize BCV for various human indications. Chimerix, Inc. was incorporated in 2000 and is headquartered in Durham, North Carolina.

और पढ़ें

तकनीकी सारांश

प्रकार
5 मिनट
15 मिनट
प्रति घंटा
दैनिक
मासिक
मूविंग एवरेजमजबूत खरीदमजबूत खरीदमजबूत खरीदतटस्थमजबूत विक्रय
तकनीकी संकेतकमजबूत खरीदमजबूत खरीदमजबूत विक्रयमजबूत खरीदमजबूत विक्रय
सारांशमजबूत खरीदमजबूत खरीदतटस्थखरीदेंमजबूत विक्रय